References
- Sirintrapun SJ, Lopez AM. Telemedicine in cancer care. Am Soc Clin Oncol Educ Book 2018;38:540-5.
- Royce TJ, Sanoff HK, Rewari A. Telemedicine for cancer care in the time of COVID-19. JAMA Oncol 2020;6:1698-9.
- Yadav K, Ginsburg O, Basu P, Mehrotra R. Telemedicine and cancer care in low-and middle-income countries during the SARS-CoV-2 pandemic. JCO Glob Oncol 2021;7:1633-8.
- Gondal H, Abbas T, Choquette H, Le D, Chalchal HI, Iqbal N, et al. Patient and physician satisfaction with telemedicine in cancer care in Saskatchewan: A cross-sectional study. Curr Oncol 2022;29:3870-80.
- Roque K, Ruiz R, Otoya-Fernandez I, Galarreta J, Vidaurre T, de Mello RA, et al. The impact of telemedicine on cancer care: Real-world experience from a Peruvian institute during the COVID-19 pandemic. Future Oncol 2022;18:3501-8.
- Novara G, Checcucci E, Crestani A, Abrate A, Esperto F, Pavan N, et al. Telehealth in urology: A systematic review of the literature. How much can telemedicine be useful during and after the COVID-19 pandemic? Eur Urol 2020;78:786-811.
- Panet F, Tétreault-Langlois M, Morin V, Sultanem K, Melnychuk D, Panasci L. The risks associated with the widespread use of telemedicine in oncology: Four cases and review of the literature. Cancer Rep (Hoboken) 2022;5:e1531.
- Edge SB, Compton CC. The American joint committee on cancer: The 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 2010;17:1471-4.
- Bidoli E, Virdone S, Hamdi-Cherif M, Toffolutti F, Taborelli M, Panato C, et al. Worldwide age at onset of female breast cancer: A 25-year population-based cancer registry study. Sci Rep 2019;9:14111.
- Satagopan JM, Stroup A, Kinney AY, Dharamdasani T, Ganesan S, Bandera EV. Breast cancer among Asian Indian and Pakistani Americans: A surveillance, epidemiology and end results-based study. Int J Cancer 2021;148:1598-607.
- Alrahawy M, Johnson C, Aker M, Eltyeb HA, Green S. Impact of COVID-19 on the mode of presentation and stage at diagnosis of colorectal cancer. Cureus 2022;14:e32037.
- İlgün AS, Özmen V. The impact of the COVID-19 pandemic on breast cancer patients. Eur J Breast Health 2022;18:85-90.
- Nyante SJ, Benefield TS, Kuzmiak CM, Earnhardt K, Pritchard M, Henderson LM. Population‐level impact of coronavirus disease 2019 on breast cancer screening and diagnostic procedures. Cancer 2021;127:2111-21.
- Miller MM, Meneveau MO, Rochman CM, Schroen AT, Lattimore CM, Gaspard PA, et al. Impact of the COVID-19 pandemic on breast cancer screening volumes and patient screening behaviors. Breast Cancer Res Treat 2021;189:237-46.
- Elkaddoum R, Haddad FG, Eid R, Kourie HR. Telemedicine for cancer patients during COVID-19 pandemic: Between threats and opportunities. Future Oncol 2020;16:1225-7.
- Shirke MM, Shaikh SA, Harky A. Implications of telemedicine in oncology during the COVID-19 pandemic. Acta Biomed 2020;91:e2020022.
- Greene G, Griffiths R, Han J, Akbari A, Jones M, Lyons J, et al. Impact of the SARS-CoV-2 pandemic on female breast, colorectal and non-small cell lung cancer incidence, stage and healthcare pathway to diagnosis during 2020 in Wales, UK, using a national cancer clinical record system. Br J Cancer 2022;127:558-68.
- Zhou Y, Yang Q, Ye J, Wu X, Hou X, Feng Y, et al. Clinical features and death risk factors in COVID-19 patients with cancer: A retrospective study. BMC Infect Dis 2021;21:760.
- Lafourcade A, His M, Baglietto L, Boutron-Ruault MC, Dossus L, Rondeau V. Factors associated with breast cancer recurrences or mortality and dynamic prediction of death using history of cancer recurrences: The French E3N cohort. BMC Cancer 2018;18:171.
- Mauguen A, Rachet B, Mathoulin-Pélissier S, Lawrence GM, Siesling S, MacGrogan G, et al. Validation of death prediction after breast cancer relapses using joint models. BMC Med Res Methodol 2015;15:27.
- Dent R, Valentini A, Hanna W, Rawlinson E, Rakovitch E, Sun P, et al. Factors associated with breast cancer mortality after local recurrence. Curr Oncol 2014;21:e418-25.
- San Miguel Y, Gomez SL, Murphy JD, Schwab RB, McDaniels-Davidson C, Canchola AJ, et al. Age-related differences in breast cancer mortality according to race/ethnicity, insurance, and socioeconomic status. BMC Cancer 2020;20:228.
- Vatansev H, Kadiyoran C, Cumhur Cure M, Cure E. COVID-19 infection can cause chemotherapy resistance development in patients with breast cancer and tamoxifen may cause susceptibility to COVID-19 infection. Med Hypotheses 2020;143:110091.
- Bhatti AB, Jamshed A, Shah M, Khan A. Breast conservative therapy in Pakistani women: Prognostic factors for locoregional recurrence and overall survival. J Cancer Res Ther 2015;11:300-4.
- Leatherdale ST. Natural experiment methodology for research: A review of how different methods can support real-world research. Int J Soc Res Methodol 2019;22:19-35.